nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—ABCB1—Methylprednisolone—psoriatic arthritis	0.0556	0.0797	CbGbCtD
Fluvoxamine—CYP1A1—Dexamethasone—psoriatic arthritis	0.0539	0.0772	CbGbCtD
Fluvoxamine—CYP3A7—Dexamethasone—psoriatic arthritis	0.0431	0.0617	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0431	0.0617	CbGbCtD
Fluvoxamine—CYP2C19—Prednisone—psoriatic arthritis	0.0418	0.0598	CbGbCtD
Fluvoxamine—CYP2E1—Dexamethasone—psoriatic arthritis	0.0416	0.0596	CbGbCtD
Fluvoxamine—CYP2B6—Dexamethasone—psoriatic arthritis	0.041	0.0588	CbGbCtD
Fluvoxamine—ABCB1—Betamethasone—psoriatic arthritis	0.0362	0.0518	CbGbCtD
Fluvoxamine—ABCB1—Prednisolone—psoriatic arthritis	0.0357	0.0511	CbGbCtD
Fluvoxamine—ABCB1—Prednisone—psoriatic arthritis	0.0337	0.0483	CbGbCtD
Fluvoxamine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0333	0.0478	CbGbCtD
Fluvoxamine—CYP3A5—Dexamethasone—psoriatic arthritis	0.0323	0.0463	CbGbCtD
Fluvoxamine—CYP2C19—Dexamethasone—psoriatic arthritis	0.0261	0.0374	CbGbCtD
Fluvoxamine—CYP3A4—Triamcinolone—psoriatic arthritis	0.0253	0.0362	CbGbCtD
Fluvoxamine—CYP2C9—Dexamethasone—psoriatic arthritis	0.0217	0.0311	CbGbCtD
Fluvoxamine—CYP3A4—Betamethasone—psoriatic arthritis	0.0217	0.031	CbGbCtD
Fluvoxamine—CYP3A4—Prednisolone—psoriatic arthritis	0.0214	0.0306	CbGbCtD
Fluvoxamine—ABCB1—Dexamethasone—psoriatic arthritis	0.021	0.0301	CbGbCtD
Fluvoxamine—CYP3A4—Prednisone—psoriatic arthritis	0.0202	0.0289	CbGbCtD
Fluvoxamine—CYP2D6—Dexamethasone—psoriatic arthritis	0.0198	0.0284	CbGbCtD
Fluvoxamine—ABCB1—Methotrexate—psoriatic arthritis	0.0169	0.0242	CbGbCtD
Fluvoxamine—CYP3A4—Dexamethasone—psoriatic arthritis	0.0126	0.0181	CbGbCtD
Fluvoxamine—Sweating—Methotrexate—psoriatic arthritis	0.000211	0.0007	CcSEcCtD
Fluvoxamine—Infection—Methylprednisolone—psoriatic arthritis	0.000211	0.000699	CcSEcCtD
Fluvoxamine—Haematuria—Methotrexate—psoriatic arthritis	0.00021	0.000696	CcSEcCtD
Fluvoxamine—Shock—Triamcinolone—psoriatic arthritis	0.000209	0.000693	CcSEcCtD
Fluvoxamine—Insomnia—Prednisolone—psoriatic arthritis	0.000209	0.000693	CcSEcCtD
Fluvoxamine—Alopecia—Prednisone—psoriatic arthritis	0.000209	0.000693	CcSEcCtD
Fluvoxamine—Shock—Methylprednisolone—psoriatic arthritis	0.000209	0.000692	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000208	0.00069	CcSEcCtD
Fluvoxamine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000208	0.00069	CcSEcCtD
Fluvoxamine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000208	0.000689	CcSEcCtD
Fluvoxamine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000208	0.000689	CcSEcCtD
Fluvoxamine—Epistaxis—Methotrexate—psoriatic arthritis	0.000208	0.000688	CcSEcCtD
Fluvoxamine—Paraesthesia—Prednisolone—psoriatic arthritis	0.000208	0.000688	CcSEcCtD
Fluvoxamine—Tachycardia—Triamcinolone—psoriatic arthritis	0.000208	0.000688	CcSEcCtD
Fluvoxamine—Mental disorder—Prednisone—psoriatic arthritis	0.000207	0.000687	CcSEcCtD
Fluvoxamine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000207	0.000686	CcSEcCtD
Fluvoxamine—Malnutrition—Prednisone—psoriatic arthritis	0.000206	0.000682	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000206	0.000681	CcSEcCtD
Fluvoxamine—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000206	0.000681	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000205	0.00068	CcSEcCtD
Fluvoxamine—Convulsion—Dexamethasone—psoriatic arthritis	0.000205	0.000679	CcSEcCtD
Fluvoxamine—Convulsion—Betamethasone—psoriatic arthritis	0.000205	0.000679	CcSEcCtD
Fluvoxamine—Hypertension—Betamethasone—psoriatic arthritis	0.000204	0.000676	CcSEcCtD
Fluvoxamine—Hypertension—Dexamethasone—psoriatic arthritis	0.000204	0.000676	CcSEcCtD
Fluvoxamine—Myalgia—Betamethasone—psoriatic arthritis	0.000202	0.000667	CcSEcCtD
Fluvoxamine—Myalgia—Dexamethasone—psoriatic arthritis	0.000202	0.000667	CcSEcCtD
Fluvoxamine—Anxiety—Dexamethasone—psoriatic arthritis	0.000201	0.000665	CcSEcCtD
Fluvoxamine—Anxiety—Betamethasone—psoriatic arthritis	0.000201	0.000665	CcSEcCtD
Fluvoxamine—Discomfort—Dexamethasone—psoriatic arthritis	0.000199	0.000659	CcSEcCtD
Fluvoxamine—Discomfort—Betamethasone—psoriatic arthritis	0.000199	0.000659	CcSEcCtD
Fluvoxamine—Haemoglobin—Methotrexate—psoriatic arthritis	0.000199	0.000658	CcSEcCtD
Fluvoxamine—Hypotension—Methylprednisolone—psoriatic arthritis	0.000198	0.000657	CcSEcCtD
Fluvoxamine—Pain—Prednisolone—psoriatic arthritis	0.000198	0.000655	CcSEcCtD
Fluvoxamine—Hepatitis—Methotrexate—psoriatic arthritis	0.000198	0.000655	CcSEcCtD
Fluvoxamine—Haemorrhage—Methotrexate—psoriatic arthritis	0.000198	0.000655	CcSEcCtD
Fluvoxamine—Pharyngitis—Methotrexate—psoriatic arthritis	0.000196	0.00065	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000195	0.000647	CcSEcCtD
Fluvoxamine—Vision blurred—Prednisone—psoriatic arthritis	0.000194	0.000643	CcSEcCtD
Fluvoxamine—Urethral disorder—Methotrexate—psoriatic arthritis	0.000194	0.000642	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000194	0.000642	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000194	0.000641	CcSEcCtD
Fluvoxamine—Oedema—Dexamethasone—psoriatic arthritis	0.000193	0.000639	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000193	0.000639	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000193	0.000639	CcSEcCtD
Fluvoxamine—Oedema—Betamethasone—psoriatic arthritis	0.000193	0.000639	CcSEcCtD
Fluvoxamine—Insomnia—Triamcinolone—psoriatic arthritis	0.000193	0.000637	CcSEcCtD
Fluvoxamine—Insomnia—Methylprednisolone—psoriatic arthritis	0.000192	0.000636	CcSEcCtD
Fluvoxamine—Infection—Dexamethasone—psoriatic arthritis	0.000192	0.000635	CcSEcCtD
Fluvoxamine—Infection—Betamethasone—psoriatic arthritis	0.000192	0.000635	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000191	0.000633	CcSEcCtD
Fluvoxamine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000191	0.000633	CcSEcCtD
Fluvoxamine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000191	0.000631	CcSEcCtD
Fluvoxamine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000191	0.000631	CcSEcCtD
Fluvoxamine—Visual impairment—Methotrexate—psoriatic arthritis	0.000191	0.000631	CcSEcCtD
Fluvoxamine—Anaemia—Prednisone—psoriatic arthritis	0.000191	0.000631	CcSEcCtD
Fluvoxamine—Shock—Betamethasone—psoriatic arthritis	0.00019	0.000629	CcSEcCtD
Fluvoxamine—Shock—Dexamethasone—psoriatic arthritis	0.00019	0.000629	CcSEcCtD
Fluvoxamine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00019	0.000628	CcSEcCtD
Fluvoxamine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000189	0.000627	CcSEcCtD
Fluvoxamine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000189	0.000627	CcSEcCtD
Fluvoxamine—Agitation—Prednisone—psoriatic arthritis	0.000189	0.000627	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000189	0.000626	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000189	0.000626	CcSEcCtD
Fluvoxamine—Tachycardia—Betamethasone—psoriatic arthritis	0.000189	0.000624	CcSEcCtD
Fluvoxamine—Tachycardia—Dexamethasone—psoriatic arthritis	0.000189	0.000624	CcSEcCtD
Fluvoxamine—Angioedema—Prednisone—psoriatic arthritis	0.000188	0.000623	CcSEcCtD
Fluvoxamine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000187	0.00062	CcSEcCtD
Fluvoxamine—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000187	0.000619	CcSEcCtD
Fluvoxamine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000187	0.000619	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000187	0.000618	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000187	0.000618	CcSEcCtD
Fluvoxamine—Malaise—Prednisone—psoriatic arthritis	0.000186	0.000615	CcSEcCtD
Fluvoxamine—Vertigo—Prednisone—psoriatic arthritis	0.000185	0.000613	CcSEcCtD
Fluvoxamine—Eye disorder—Methotrexate—psoriatic arthritis	0.000185	0.000612	CcSEcCtD
Fluvoxamine—Syncope—Prednisone—psoriatic arthritis	0.000185	0.000612	CcSEcCtD
Fluvoxamine—Tinnitus—Methotrexate—psoriatic arthritis	0.000185	0.000611	CcSEcCtD
Fluvoxamine—Anorexia—Dexamethasone—psoriatic arthritis	0.000184	0.00061	CcSEcCtD
Fluvoxamine—Anorexia—Betamethasone—psoriatic arthritis	0.000184	0.00061	CcSEcCtD
Fluvoxamine—Urticaria—Prednisolone—psoriatic arthritis	0.000184	0.000609	CcSEcCtD
Fluvoxamine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000184	0.000608	CcSEcCtD
Fluvoxamine—Fatigue—Triamcinolone—psoriatic arthritis	0.000184	0.000608	CcSEcCtD
Fluvoxamine—Fatigue—Methylprednisolone—psoriatic arthritis	0.000183	0.000606	CcSEcCtD
Fluvoxamine—Pain—Triamcinolone—psoriatic arthritis	0.000182	0.000603	CcSEcCtD
Fluvoxamine—Loss of consciousness—Prednisone—psoriatic arthritis	0.000181	0.0006	CcSEcCtD
Fluvoxamine—Hypotension—Dexamethasone—psoriatic arthritis	0.000181	0.000598	CcSEcCtD
Fluvoxamine—Hypotension—Betamethasone—psoriatic arthritis	0.000181	0.000598	CcSEcCtD
Fluvoxamine—Angiopathy—Methotrexate—psoriatic arthritis	0.00018	0.000594	CcSEcCtD
Fluvoxamine—Convulsion—Prednisone—psoriatic arthritis	0.000179	0.000591	CcSEcCtD
Fluvoxamine—Hypertension—Prednisone—psoriatic arthritis	0.000178	0.000589	CcSEcCtD
Fluvoxamine—Chills—Methotrexate—psoriatic arthritis	0.000178	0.000588	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000176	0.000583	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000176	0.000583	CcSEcCtD
Fluvoxamine—Arthralgia—Prednisone—psoriatic arthritis	0.000175	0.000581	CcSEcCtD
Fluvoxamine—Myalgia—Prednisone—psoriatic arthritis	0.000175	0.000581	CcSEcCtD
Fluvoxamine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000175	0.000581	CcSEcCtD
Fluvoxamine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000175	0.000579	CcSEcCtD
Fluvoxamine—Anxiety—Prednisone—psoriatic arthritis	0.000175	0.000579	CcSEcCtD
Fluvoxamine—Alopecia—Methotrexate—psoriatic arthritis	0.000175	0.000579	CcSEcCtD
Fluvoxamine—Insomnia—Betamethasone—psoriatic arthritis	0.000175	0.000578	CcSEcCtD
Fluvoxamine—Insomnia—Dexamethasone—psoriatic arthritis	0.000175	0.000578	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000174	0.000575	CcSEcCtD
Fluvoxamine—Paraesthesia—Betamethasone—psoriatic arthritis	0.000173	0.000574	CcSEcCtD
Fluvoxamine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000173	0.000574	CcSEcCtD
Fluvoxamine—Discomfort—Prednisone—psoriatic arthritis	0.000173	0.000574	CcSEcCtD
Fluvoxamine—Mental disorder—Methotrexate—psoriatic arthritis	0.000173	0.000574	CcSEcCtD
Fluvoxamine—Malnutrition—Methotrexate—psoriatic arthritis	0.000172	0.00057	CcSEcCtD
Fluvoxamine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000171	0.000565	CcSEcCtD
Fluvoxamine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00017	0.000563	CcSEcCtD
Fluvoxamine—Dyspepsia—Betamethasone—psoriatic arthritis	0.00017	0.000563	CcSEcCtD
Fluvoxamine—Urticaria—Triamcinolone—psoriatic arthritis	0.000169	0.00056	CcSEcCtD
Fluvoxamine—Urticaria—Methylprednisolone—psoriatic arthritis	0.000169	0.000559	CcSEcCtD
Fluvoxamine—Dysgeusia—Methotrexate—psoriatic arthritis	0.000169	0.000558	CcSEcCtD
Fluvoxamine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000168	0.000557	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000168	0.000557	CcSEcCtD
Fluvoxamine—Oedema—Prednisone—psoriatic arthritis	0.000168	0.000557	CcSEcCtD
Fluvoxamine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000168	0.000556	CcSEcCtD
Fluvoxamine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000168	0.000556	CcSEcCtD
Fluvoxamine—Decreased appetite—Betamethasone—psoriatic arthritis	0.000168	0.000556	CcSEcCtD
Fluvoxamine—Infection—Prednisone—psoriatic arthritis	0.000167	0.000553	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000167	0.000552	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000167	0.000552	CcSEcCtD
Fluvoxamine—Back pain—Methotrexate—psoriatic arthritis	0.000167	0.000552	CcSEcCtD
Fluvoxamine—Fatigue—Dexamethasone—psoriatic arthritis	0.000167	0.000551	CcSEcCtD
Fluvoxamine—Fatigue—Betamethasone—psoriatic arthritis	0.000167	0.000551	CcSEcCtD
Fluvoxamine—Shock—Prednisone—psoriatic arthritis	0.000166	0.000548	CcSEcCtD
Fluvoxamine—Pain—Betamethasone—psoriatic arthritis	0.000165	0.000547	CcSEcCtD
Fluvoxamine—Pain—Dexamethasone—psoriatic arthritis	0.000165	0.000547	CcSEcCtD
Fluvoxamine—Nervous system disorder—Prednisone—psoriatic arthritis	0.000165	0.000546	CcSEcCtD
Fluvoxamine—Tachycardia—Prednisone—psoriatic arthritis	0.000164	0.000543	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000163	0.000538	CcSEcCtD
Fluvoxamine—Vision blurred—Methotrexate—psoriatic arthritis	0.000162	0.000537	CcSEcCtD
Fluvoxamine—Anorexia—Prednisone—psoriatic arthritis	0.00016	0.000531	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00016	0.000529	CcSEcCtD
Fluvoxamine—Anaemia—Methotrexate—psoriatic arthritis	0.000159	0.000527	CcSEcCtD
Fluvoxamine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000159	0.000527	CcSEcCtD
Fluvoxamine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000159	0.000527	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000158	0.000523	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000158	0.000523	CcSEcCtD
Fluvoxamine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000157	0.000519	CcSEcCtD
Fluvoxamine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000157	0.000518	CcSEcCtD
Fluvoxamine—Malaise—Methotrexate—psoriatic arthritis	0.000155	0.000514	CcSEcCtD
Fluvoxamine—Vertigo—Methotrexate—psoriatic arthritis	0.000155	0.000512	CcSEcCtD
Fluvoxamine—Leukopenia—Methotrexate—psoriatic arthritis	0.000154	0.00051	CcSEcCtD
Fluvoxamine—Urticaria—Betamethasone—psoriatic arthritis	0.000153	0.000508	CcSEcCtD
Fluvoxamine—Urticaria—Dexamethasone—psoriatic arthritis	0.000153	0.000508	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000153	0.000507	CcSEcCtD
Fluvoxamine—Dizziness—Prednisolone—psoriatic arthritis	0.000153	0.000507	CcSEcCtD
Fluvoxamine—Asthenia—Triamcinolone—psoriatic arthritis	0.000153	0.000506	CcSEcCtD
Fluvoxamine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000153	0.000505	CcSEcCtD
Fluvoxamine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000153	0.000505	CcSEcCtD
Fluvoxamine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000153	0.000505	CcSEcCtD
Fluvoxamine—Body temperature increased—Betamethasone—psoriatic arthritis	0.000153	0.000505	CcSEcCtD
Fluvoxamine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000152	0.000504	CcSEcCtD
Fluvoxamine—Insomnia—Prednisone—psoriatic arthritis	0.000152	0.000504	CcSEcCtD
Fluvoxamine—Paraesthesia—Prednisone—psoriatic arthritis	0.000151	0.0005	CcSEcCtD
Fluvoxamine—Pruritus—Triamcinolone—psoriatic arthritis	0.000151	0.000499	CcSEcCtD
Fluvoxamine—Cough—Methotrexate—psoriatic arthritis	0.00015	0.000498	CcSEcCtD
Fluvoxamine—Pruritus—Methylprednisolone—psoriatic arthritis	0.00015	0.000497	CcSEcCtD
Fluvoxamine—Convulsion—Methotrexate—psoriatic arthritis	0.000149	0.000494	CcSEcCtD
Fluvoxamine—Dyspepsia—Prednisone—psoriatic arthritis	0.000148	0.00049	CcSEcCtD
Fluvoxamine—Arthralgia—Methotrexate—psoriatic arthritis	0.000147	0.000485	CcSEcCtD
Fluvoxamine—Myalgia—Methotrexate—psoriatic arthritis	0.000147	0.000485	CcSEcCtD
Fluvoxamine—Chest pain—Methotrexate—psoriatic arthritis	0.000147	0.000485	CcSEcCtD
Fluvoxamine—Decreased appetite—Prednisone—psoriatic arthritis	0.000146	0.000484	CcSEcCtD
Fluvoxamine—Rash—Prednisolone—psoriatic arthritis	0.000146	0.000483	CcSEcCtD
Fluvoxamine—Dermatitis—Prednisolone—psoriatic arthritis	0.000146	0.000483	CcSEcCtD
Fluvoxamine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000145	0.000481	CcSEcCtD
Fluvoxamine—Fatigue—Prednisone—psoriatic arthritis	0.000145	0.00048	CcSEcCtD
Fluvoxamine—Headache—Prednisolone—psoriatic arthritis	0.000145	0.00048	CcSEcCtD
Fluvoxamine—Discomfort—Methotrexate—psoriatic arthritis	0.000145	0.00048	CcSEcCtD
Fluvoxamine—Constipation—Prednisone—psoriatic arthritis	0.000144	0.000476	CcSEcCtD
Fluvoxamine—Confusional state—Methotrexate—psoriatic arthritis	0.000142	0.000469	CcSEcCtD
Fluvoxamine—Dizziness—Triamcinolone—psoriatic arthritis	0.000141	0.000466	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000141	0.000465	CcSEcCtD
Fluvoxamine—Dizziness—Methylprednisolone—psoriatic arthritis	0.00014	0.000465	CcSEcCtD
Fluvoxamine—Infection—Methotrexate—psoriatic arthritis	0.00014	0.000462	CcSEcCtD
Fluvoxamine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000139	0.000459	CcSEcCtD
Fluvoxamine—Asthenia—Dexamethasone—psoriatic arthritis	0.000139	0.000459	CcSEcCtD
Fluvoxamine—Asthenia—Betamethasone—psoriatic arthritis	0.000139	0.000459	CcSEcCtD
Fluvoxamine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000138	0.000456	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000138	0.000456	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000138	0.000455	CcSEcCtD
Fluvoxamine—Nausea—Prednisolone—psoriatic arthritis	0.000138	0.000455	CcSEcCtD
Fluvoxamine—Pruritus—Dexamethasone—psoriatic arthritis	0.000137	0.000452	CcSEcCtD
Fluvoxamine—Pruritus—Betamethasone—psoriatic arthritis	0.000137	0.000452	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000136	0.00045	CcSEcCtD
Fluvoxamine—Vomiting—Triamcinolone—psoriatic arthritis	0.000135	0.000448	CcSEcCtD
Fluvoxamine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000135	0.000447	CcSEcCtD
Fluvoxamine—Rash—Triamcinolone—psoriatic arthritis	0.000134	0.000444	CcSEcCtD
Fluvoxamine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000134	0.000444	CcSEcCtD
Fluvoxamine—Anorexia—Methotrexate—psoriatic arthritis	0.000134	0.000444	CcSEcCtD
Fluvoxamine—Rash—Methylprednisolone—psoriatic arthritis	0.000134	0.000443	CcSEcCtD
Fluvoxamine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000134	0.000443	CcSEcCtD
Fluvoxamine—Urticaria—Prednisone—psoriatic arthritis	0.000134	0.000442	CcSEcCtD
Fluvoxamine—Headache—Triamcinolone—psoriatic arthritis	0.000133	0.000441	CcSEcCtD
Fluvoxamine—Headache—Methylprednisolone—psoriatic arthritis	0.000133	0.000441	CcSEcCtD
Fluvoxamine—Body temperature increased—Prednisone—psoriatic arthritis	0.000133	0.00044	CcSEcCtD
Fluvoxamine—Abdominal pain—Prednisone—psoriatic arthritis	0.000133	0.00044	CcSEcCtD
Fluvoxamine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000132	0.000438	CcSEcCtD
Fluvoxamine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000132	0.000438	CcSEcCtD
Fluvoxamine—Hypotension—Methotrexate—psoriatic arthritis	0.000131	0.000435	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000128	0.000424	CcSEcCtD
Fluvoxamine—Dizziness—Betamethasone—psoriatic arthritis	0.000128	0.000423	CcSEcCtD
Fluvoxamine—Dizziness—Dexamethasone—psoriatic arthritis	0.000128	0.000423	CcSEcCtD
Fluvoxamine—Insomnia—Methotrexate—psoriatic arthritis	0.000127	0.000421	CcSEcCtD
Fluvoxamine—Nausea—Triamcinolone—psoriatic arthritis	0.000126	0.000419	CcSEcCtD
Fluvoxamine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000126	0.000418	CcSEcCtD
Fluvoxamine—Nausea—Methylprednisolone—psoriatic arthritis	0.000126	0.000418	CcSEcCtD
Fluvoxamine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000125	0.000415	CcSEcCtD
Fluvoxamine—Somnolence—Methotrexate—psoriatic arthritis	0.000125	0.000414	CcSEcCtD
Fluvoxamine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000124	0.00041	CcSEcCtD
Fluvoxamine—Dyspepsia—Methotrexate—psoriatic arthritis	0.000124	0.00041	CcSEcCtD
Fluvoxamine—Vomiting—Dexamethasone—psoriatic arthritis	0.000123	0.000407	CcSEcCtD
Fluvoxamine—Vomiting—Betamethasone—psoriatic arthritis	0.000123	0.000407	CcSEcCtD
Fluvoxamine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000122	0.000405	CcSEcCtD
Fluvoxamine—Rash—Betamethasone—psoriatic arthritis	0.000122	0.000403	CcSEcCtD
Fluvoxamine—Rash—Dexamethasone—psoriatic arthritis	0.000122	0.000403	CcSEcCtD
Fluvoxamine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000122	0.000403	CcSEcCtD
Fluvoxamine—Dermatitis—Betamethasone—psoriatic arthritis	0.000122	0.000403	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000121	0.000402	CcSEcCtD
Fluvoxamine—Fatigue—Methotrexate—psoriatic arthritis	0.000121	0.000401	CcSEcCtD
Fluvoxamine—Headache—Betamethasone—psoriatic arthritis	0.000121	0.000401	CcSEcCtD
Fluvoxamine—Headache—Dexamethasone—psoriatic arthritis	0.000121	0.000401	CcSEcCtD
Fluvoxamine—Asthenia—Prednisone—psoriatic arthritis	0.000121	0.0004	CcSEcCtD
Fluvoxamine—Pain—Methotrexate—psoriatic arthritis	0.00012	0.000398	CcSEcCtD
Fluvoxamine—Pruritus—Prednisone—psoriatic arthritis	0.000119	0.000394	CcSEcCtD
Fluvoxamine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000116	0.000384	CcSEcCtD
Fluvoxamine—Diarrhoea—Prednisone—psoriatic arthritis	0.000115	0.000381	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000115	0.000381	CcSEcCtD
Fluvoxamine—Nausea—Betamethasone—psoriatic arthritis	0.000115	0.00038	CcSEcCtD
Fluvoxamine—Nausea—Dexamethasone—psoriatic arthritis	0.000115	0.00038	CcSEcCtD
Fluvoxamine—Urticaria—Methotrexate—psoriatic arthritis	0.000112	0.00037	CcSEcCtD
Fluvoxamine—Dizziness—Prednisone—psoriatic arthritis	0.000111	0.000368	CcSEcCtD
Fluvoxamine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000111	0.000368	CcSEcCtD
Fluvoxamine—Body temperature increased—Methotrexate—psoriatic arthritis	0.000111	0.000368	CcSEcCtD
Fluvoxamine—Vomiting—Prednisone—psoriatic arthritis	0.000107	0.000354	CcSEcCtD
Fluvoxamine—Rash—Prednisone—psoriatic arthritis	0.000106	0.000351	CcSEcCtD
Fluvoxamine—Dermatitis—Prednisone—psoriatic arthritis	0.000106	0.000351	CcSEcCtD
Fluvoxamine—Headache—Prednisone—psoriatic arthritis	0.000105	0.000349	CcSEcCtD
Fluvoxamine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000104	0.000343	CcSEcCtD
Fluvoxamine—Asthenia—Methotrexate—psoriatic arthritis	0.000101	0.000334	CcSEcCtD
Fluvoxamine—Nausea—Prednisone—psoriatic arthritis	9.99e-05	0.000331	CcSEcCtD
Fluvoxamine—Pruritus—Methotrexate—psoriatic arthritis	9.95e-05	0.000329	CcSEcCtD
Fluvoxamine—Diarrhoea—Methotrexate—psoriatic arthritis	9.62e-05	0.000318	CcSEcCtD
Fluvoxamine—Dizziness—Methotrexate—psoriatic arthritis	9.3e-05	0.000308	CcSEcCtD
Fluvoxamine—Vomiting—Methotrexate—psoriatic arthritis	8.94e-05	0.000296	CcSEcCtD
Fluvoxamine—Rash—Methotrexate—psoriatic arthritis	8.86e-05	0.000293	CcSEcCtD
Fluvoxamine—Dermatitis—Methotrexate—psoriatic arthritis	8.86e-05	0.000293	CcSEcCtD
Fluvoxamine—Headache—Methotrexate—psoriatic arthritis	8.81e-05	0.000292	CcSEcCtD
Fluvoxamine—Nausea—Methotrexate—psoriatic arthritis	8.35e-05	0.000276	CcSEcCtD
